No, you do not need a prescription for enterade®, but since enterade® is a medical food, it should be used under the supervision of a healthcare provider.
Typical use is two 8 ounce bottles per day. 30 minutes before a meal or 1 hour after.
A medical food is a product that is taken orally and intended for the dietary management of your medical needs or conditions to support distinct nutrient requirements. Products in this category are not considered a drug.
enterade® is a medical food that provides select amino acids and electrolytes for the dietary management of GI function related to cancer therapy.
Clinical research has shown that enterade® can help with:
In clinical trials no reported side effect. Do not use in patients with a know allergy to stevia.
enterade® has not been reported to interfere with any medications.
Patients have used enterade® through a G tube with no reported complications. Consult healthcare provider about use of enterade® through a G tube.
Entrinsic Health Solutions, Inc., is an innovative health sciences company dedicated to the development and commercialization of amino acid based medical foods to address critical digestive health, nutrition and hydration related health issues. The Company’s proprietary Amino Acid Coupled Transport™ (A2CT) Technology platform leverages gold-standard science and game-changing amino acid technology to address critical digestive- and hydration-related health issues. A2CT technology uses select amino acids to facilitate active transport of electrolytes throughout the body, which delivers rapid hydration, decreased gut permeability and improved nutrient absorption, supporting long-term digestive health. The Company’s first commercial product, enterade® AOF, is a first-in-class amino acid based medical food beverage that hydrates, rebuilds, and protects the gut lining and helps manage side effects from cancer treatments as well as occasional diarrhea, cramping, dehydration, nausea and malnutrition. The Company is involved in several on-going clinical trials designed to test the efficacy of the A₂CT Technology for oncology and digestive health applications.